Literature DB >> 100918

Comparison of various measures of sensitivity of M. tuberculosis to ethambutol.

S Subbammal, N G Nair, S Radhakrishna, S P Tripathy.   

Abstract

A sensitivity test for ethambutol was standardised, and performed on cultures isolated from patients before and after the start of chemotherapy with ethambutol and isoniazid. A discrimination type of approach was employed and three criteria of resistance were evolved: (a) growth of 20 colonies or more on ethambutol 4 microgram/ml, using a standard inoculum; (b) a proportion of 25% or more on ethambutol 1.4 microgram/ml; (c) a proportion of 5% or more on ethambutol 2 microgram/ml. The MIC definition appears to be the best in view of its simplicity and insensitivity of the classification (as sensitive or resistant) to variations in inoculum size.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 100918     DOI: 10.1016/0041-3879(78)90025-9

Source DB:  PubMed          Journal:  Tubercle        ISSN: 0041-3879


  2 in total

1.  Multicenter evaluation of ethambutol susceptibility testing of mycobacterium tuberculosis by agar proportion and radiometric methods.

Authors:  B Madison; B Robinson-Dunn; I George; W Gross; H Lipman; B Metchock; A Sloutsky; G Washabaugh; G Mazurek; J Ridderhof
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

2.  Randomized clinical trial of thrice-weekly 4-month moxifloxacin or gatifloxacin containing regimens in the treatment of new sputum positive pulmonary tuberculosis patients.

Authors:  Mohideen S Jawahar; Vaithilingam V Banurekha; Chinnampedu N Paramasivan; Fathima Rahman; Rajeswari Ramachandran; Perumal Venkatesan; Rani Balasubramanian; Nagamiah Selvakumar; Chinnaiyan Ponnuraja; Allaudeen S Iliayas; Navaneethapandian P Gangadevi; Balambal Raman; Dhanaraj Baskaran; Santhanakrishnan R Kumar; Marimuthu M Kumar; Victor Mohan; Sudha Ganapathy; Vanaja Kumar; Geetha Shanmugam; Niruparani Charles; Murugesan R Sakthivel; Kannivelu Jagannath; Chockalingam Chandrasekar; Ramavaram T Parthasarathy; Paranji R Narayanan
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.